Aldo Pietro Maggioni

Summary

Affiliation: ANMCO Research Center
Country: Italy

Publications

  1. ncbi request reprint RAAS inhibitors in the cardiovascular continuum: what is still missing?
    Aldo P Maggioni
    ANMCO Research Center, Via La Marmora 34, 5021 Florence, Italy
    Cardiovasc Drugs Ther 18:311-20. 2004
  2. pmc Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSI-AF trial
    Marcello Disertori
    Department of Cardiology, Santa Chiara Hospital, Trento, Italy
    BMC Cardiovasc Disord 13:28. 2013
  3. pmc RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers
    Harry J G M Crijns
    Maastricht University Medical Center, Maastricht, Netherlands
    BMC Cardiovasc Disord 12:85. 2012
  4. doi request reprint EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)
    Aldo P Maggioni
    ANMCO Research Center, Florence, Italy
    Eur J Heart Fail 15:808-17. 2013
  5. doi request reprint Outcomes, health costs and use of antiplatelet agents in 7,082 patients admitted for an acute coronary syndrome occurring in a large community setting
    Aldo P Maggioni
    ANMCO Research Center, Via La Marmora 34, 50121 Florence, Italy
    Cardiovasc Drugs Ther 27:333-40. 2013
  6. pmc Heterogeneity prevails: the state of clinical trial data management in Europe - results of a survey of ECRIN centres
    Wolfgang Kuchinke
    Coordination Centre for Clinical Trials, Heinrich Heine University Duesseldorf, Duesseldorf, Germany
    Trials 11:79. 2010
  7. ncbi request reprint Efficacy of Angiotensin receptor blockers in cardiovascular disease
    Aldo P Maggioni
    ANMCO Research Center, Italian Association of Hospital Cardiologists, Via La Marmora 34, 50121, Florence, Italy
    Cardiovasc Drugs Ther 20:295-308. 2006
  8. ncbi request reprint VALIANT (VALsartan In Acute myocardial iNfarcTion) trial
    Aldo Pietro Maggioni
    ANMCO Research Center, Via La Marmora 34, 50121 Florence, Italy
    Expert Opin Pharmacother 6:507-12. 2005
  9. ncbi request reprint Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT)
    Aldo P Maggioni
    ANMCO Research Center, Florence, Italy
    Am Heart J 149:548-57. 2005
  10. doi request reprint Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial
    Aldo P Maggioni
    GISSI HF Coordinating Center, ANMCO Research Center, Via La Marmora, 34, 50121 Florence, Italy
    Eur Heart J 30:2327-36. 2009

Detail Information

Publications59

  1. ncbi request reprint RAAS inhibitors in the cardiovascular continuum: what is still missing?
    Aldo P Maggioni
    ANMCO Research Center, Via La Marmora 34, 5021 Florence, Italy
    Cardiovasc Drugs Ther 18:311-20. 2004
    ..Examples of these points, particularly regarding the size of modern cardiovascular trials to have the power to show protective effects, are illustrated by Val-HeFT, LIFE, ELITE II, VALIANT, VALUE, CHARM and NAVIGATOR...
  2. pmc Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSI-AF trial
    Marcello Disertori
    Department of Cardiology, Santa Chiara Hospital, Trento, Italy
    BMC Cardiovasc Disord 13:28. 2013
    ..Few data on the thromboembolic (TE) risk of paroxysmal and persistent atrial fibrillation (AF) are available. This study aimed to assess the incidence of TE events in paroxysmal and persistent AF...
  3. pmc RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers
    Harry J G M Crijns
    Maastricht University Medical Center, Maastricht, Netherlands
    BMC Cardiovasc Disord 12:85. 2012
    ..There are limited data on the variation in treatment practice patterns across different countries, healthcare settings and the associated health outcomes...
  4. doi request reprint EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)
    Aldo P Maggioni
    ANMCO Research Center, Florence, Italy
    Eur J Heart Fail 15:808-17. 2013
    ..The pilot phase was also specifically aimed at validating structure, performance, and quality of the data set for continuing the survey into a permanent Registry...
  5. doi request reprint Outcomes, health costs and use of antiplatelet agents in 7,082 patients admitted for an acute coronary syndrome occurring in a large community setting
    Aldo P Maggioni
    ANMCO Research Center, Via La Marmora 34, 50121 Florence, Italy
    Cardiovasc Drugs Ther 27:333-40. 2013
    ..To assess the outcomes of patients admitted for ACS and the prescription pattern of antiplatelets of patients discharged alive...
  6. pmc Heterogeneity prevails: the state of clinical trial data management in Europe - results of a survey of ECRIN centres
    Wolfgang Kuchinke
    Coordination Centre for Clinical Trials, Heinrich Heine University Duesseldorf, Duesseldorf, Germany
    Trials 11:79. 2010
    ....
  7. ncbi request reprint Efficacy of Angiotensin receptor blockers in cardiovascular disease
    Aldo P Maggioni
    ANMCO Research Center, Italian Association of Hospital Cardiologists, Via La Marmora 34, 50121, Florence, Italy
    Cardiovasc Drugs Ther 20:295-308. 2006
    ..In addition, ARBs have been shown to provide protective effects in patients with impaired renal function or left ventricular hypertrophy. Additional clinical trials are ongoing to further characterize the role of ARBs in CVD management...
  8. ncbi request reprint VALIANT (VALsartan In Acute myocardial iNfarcTion) trial
    Aldo Pietro Maggioni
    ANMCO Research Center, Via La Marmora 34, 50121 Florence, Italy
    Expert Opin Pharmacother 6:507-12. 2005
    ..7 months of follow-up. Valsartan was not inferior to captopril in terms of total mortality and cardiovascular death, MI and HF. Valsartan can be considered an alternative treatment to ACE-I in these patients...
  9. ncbi request reprint Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT)
    Aldo P Maggioni
    ANMCO Research Center, Florence, Italy
    Am Heart J 149:548-57. 2005
    ..The aims of these subanalyses of Val-HeFT were to assess (a) the effects of valsartan in the prevention of AF, (b) the independent predictors of this event, and (c) the prognostic role of AF occurrence...
  10. doi request reprint Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial
    Aldo P Maggioni
    GISSI HF Coordinating Center, ANMCO Research Center, Via La Marmora, 34, 50121 Florence, Italy
    Eur Heart J 30:2327-36. 2009
    ..This ancillary analysis of the GISSI-HF database aims at assessing the effect of rosuvastatin on the occurrence of atrial fibrillation (AF) in patients with chronic heart failure (HF) who were not in AF at study entry...
  11. ncbi request reprint SCOUT Trial Reports on the Safety Profile of Sibutramine in Patients with Cardiovascular Diseases
    Aldo P Maggioni
    ANMCO Research Centre, Florence, IT
    Phys Sportsmed 37:95-7. 2009
    ..Original Article: Torp-Pedersen C, Caterson I, Coutinho W, et al; SCOUT Investigators. Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trial...
  12. ncbi request reprint Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors
    Aldo P Maggioni
    ANMCO Research Center, Florence, Italy
    J Am Coll Cardiol 40:1414-21. 2002
    ....
  13. doi request reprint EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot)
    Aldo P Maggioni
    ANMCO Research Center, Florence, Italy
    Eur J Heart Fail 12:1076-84. 2010
    ..This pilot study was specifically aimed at validating the structure, performance, and quality of the data set, for continuing the survey into a permanent registry...
  14. doi request reprint Tolerability of sibutramine during a 6-week treatment period in high-risk patients with cardiovascular disease and/or diabetes: a preliminary analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) Trial
    Aldo P Maggioni
    ANMCO Research Center, Florence, Italy
    J Cardiovasc Pharmacol 52:393-402. 2008
    ..When compared with epidemiological data, overall mortality rate was low and sibutramine was well tolerated in this mainly off-label population. No new safety issues were detected...
  15. pmc Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience
    A P Maggioni
    ANMCO Research Centre, Florence, Italy
    Heart 89:299-305. 2003
    ..Despite these impressive results, implementing the use of beta blockade in clinical practice appears slow and difficult. The BRING-UP study was designed to tackle this problem...
  16. ncbi request reprint The angiotensin-receptor blockers: from antihypertensives to cardiovascular all-round medications in 10 years?
    Aldo P Maggioni
    ANMCO, Research Center, Florence, Italy
    Blood Press 11:328-38. 2002
    ..A number of large-scale studies set to report within the next few years will further determine the effects of angiotensin-receptor blockers in a range of cardiovascular indications beyond hypertension...
  17. doi request reprint Age-dependent prognostic significance of atrial fibrillation in outpatients with chronic heart failure: data from the Italian Network on Congestive Heart Failure Registry
    Samuele Baldasseroni
    Italian Association of Hospital Cardiologists Research Center, University School of Medicine, Florence, Italy
    Cardiology 116:79-88. 2010
    ..The role of atrial fibrillation (AF) in older patients with heart failure (HF) is controversial because many variables seem to influence their outcome. We investigated the predictivity of AF in 3 age groups of outpatients with HF...
  18. ncbi request reprint Anemia in patients with heart failure: prevalence and prognostic role in a controlled trial and in clinical practice
    Aldo P Maggioni
    Italian Association of Hospital Cardiologists ANMCO Research Center, Florence, Italy
    J Card Fail 11:91-8. 2005
    ....
  19. doi request reprint Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?
    Gianna Fabbri
    ANMCO Research Center, Via La Marmora 34, 50121 Florence, Italy
    Adv Ther 26:469-87. 2009
    ..Further evidence is needed on the role of therapeutic strategies on the so-called residual risk...
  20. doi request reprint Role of beta-blockers in patients admitted for worsening heart failure in a real world setting: data from the Italian Survey on Acute Heart Failure
    Francesco Orso
    ANMCO Research Center, Via La Marmora 34, 50121 Florence, Italy
    Eur J Heart Fail 11:77-84. 2009
    ..The aim of this study was to evaluate the role of BBs on in-hospital outcomes of patients admitted for worsening HF in a Cardiology setting...
  21. ncbi request reprint Intraventricular conduction defects in patients with congestive heart failure: left but not right bundle branch block is an independent predictor of prognosis. A report from the Italian Network on Congestive Heart Failure (IN-CHF database)
    Samuele Baldasseroni
    Italian Association of Hospital Cardiologists ANMCO Research Center, Florence, Italy
    Ital Heart J 4:607-13. 2003
    ..The aim of this study was to compare the association of these two intraventricular conduction defects on the prognosis of CHF...
  22. ncbi request reprint In-hospital and one-year outcomes of patients with high-risk acute myocardial infarction treated with thrombolysis or primary coronary angioplasty
    Giuseppe Steffenino
    Department of Cardiology, S Croce e Carle Hospital, Cuneo, Italy
    Ital Heart J 5:136-45. 2004
    ..The aim of this study was to observe the outcomes of high-risk patients with acute myocardial infarction treated with primary angioplasty and intravenous thrombolysis in a community setting...
  23. ncbi request reprint Baseline characteristics of patients recruited in the AREA IN-CHF study (Antiremodelling Effect of Aldosterone Receptors Blockade with Canrenone in Mild Chronic Heart Failure)
    Alessandro Boccanelli
    Department of Cardiology, San Giovanni Addolorata Hospital, Rome, Italy
    J Cardiovasc Med (Hagerstown) 8:683-91. 2007
    ..AREA IN-CHF was planned to investigate the effects of canrenone on progression of LV remodelling in mild HF...
  24. ncbi request reprint [The elderly patient with heart failure at hospital cardiology units]
    Donatella Del Sindaco
    U O di Cardiologia, IRCCS, INRCA, Roma
    Ital Heart J Suppl 3:145-53. 2002
    ..Targeted clinical trials and rigorous observational studies to favor the implementation of specific guidelines into clinical practice in the elderly are needed...
  25. ncbi request reprint Rationale and design of the GISSI-Atrial Fibrillation Trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence
    Marcello Disertori
    Department of Cardiology, S Chiara Hospital, Trento, Italy
    J Cardiovasc Med (Hagerstown) 7:29-38. 2006
    ..The GISSI-Atrial Fibrillation (AF) trial is a randomized, prospective, parallel group, placebo-controlled, multicentre study designed to test whether angiotensin II AT1-receptor blockers can reduce atrial fibrillation recurrence...
  26. ncbi request reprint Body mass index, prognosis and mode of death in chronic heart failure: results from the Valsartan Heart Failure Trial
    Mariantonietta Cicoira
    Department of Biomedical and Surgical Sciences, Section of Cardiology, University of Verona, Piazzale Stefani, 1 Verona, Italy, and Hospital General Universitari Vall D Hebron, Department of Cardiology, Barcelona, Spain
    Eur J Heart Fail 9:397-402. 2007
    ..To assess the relationship between body mass index (BMI), mortality and mode of death in chronic heart failure (CHF) patients; to define the shape of the relationship between BMI and mortality...
  27. doi request reprint Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial
    Marcello Disertori
    Department of Cardiology, Santa Chiara Hospital, Trento, Italy
    Am Heart J 162:382-9. 2011
    ..In a consistent percentage of cases, AF recurrences are asymptomatic, thus making its clinical management difficult in relation to both therapeutic efficacy and thromboembolic risk...
  28. doi request reprint The role of thrombolysis in acute ischemic stroke
    Francesco Orso
    Department of Critical Care Medicine and Surgery, Section of Geriatric Medicine, University School of Medicine, Florence, Italy
    Herz 33:498-506. 2008
    ....
  29. ncbi request reprint Use of digitalis in the treatment of heart failure: data from the Italian Network on Congestive Heart Failure (IN-CHF)
    Alberto Camerini
    Department of Cardiac Rehabilitation, La Colletta Hospital, Arenzano GE, Italy
    Ital Heart J 5:523-9. 2004
    ....
  30. doi request reprint Trial-generated profiles for implantation of electrical devices in outpatients with heart failure: real-world prevalence and 1-year outcome
    Giuseppe Boriani
    Institute of Cardiology, University of Bologna, Bologna, Italy
    J Eval Clin Pract 16:82-91. 2010
    ....
  31. ncbi request reprint Improving practice patterns in heart failure through a national cardiological network: the case of ACE-inhibitors
    Maurizio Porcu
    Heart Failure and Cardiac Transplant Unit, G Brotzu Hospital, Cagliari, Italy
    Ital Heart J 3:730-7. 2002
    ..We evaluated whether participation in a specialist network and the use of a common database would impact on the compliance with CHF guidelines...
  32. ncbi request reprint Nationwide survey on acute heart failure in cardiology ward services in Italy
    Luigi Tavazzi
    Department of Cardiology, IRCCS Policlinico S Matteo, Piazzale Golgi, 2 27100 Pavia, Italy
    Eur Heart J 27:1207-15. 2006
    ..Chronic heart failure (HF) is recognized as an important public health problem but little attention has been focused on acute-stage HF...
  33. ncbi request reprint Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure
    Samuele Baldasseroni
    Italian Association of Hospital Cardiologists Research Center, Florence, Italy
    Am Heart J 143:398-405. 2002
    ..Therefore, we carried out this analysis to determine whether LBBB is an independent predictor of mortality in CHF...
  34. ncbi request reprint Hypertrophy at ECG and its regression during treatment survey (HEART survey). Rationale, design and baseline characteristics of patients
    Paolo Verdecchia
    ANMCO Research Center, Florence, Italy
    Ital Heart J 4:479-83. 2003
    ..The aim of this study was to determine the prognostic value of baseline ECG LVH and its serial changes in a large cohort of hypertensive patients...
  35. ncbi request reprint What is the optimal reperfusion strategy for elderly patients with acute MI?
    Francesco Orso
    Department of Critical Care Medicine and Surgery, University School of Medicine, Florence, Italy
    Am J Geriatr Cardiol 15:14-8. 2006
    ....
  36. ncbi request reprint A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)-Prevenzione scoring
    Alejandro Macchia
    Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti, Italy
    Am Heart J 151:754.e7-754.e17. 2006
    ..We aimed to generate a diagnostic score for MS (MS-Score), aimed at predicting diabetes by giving appropriate weight to the individual components of MS...
  37. ncbi request reprint Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure
    Luigi Tavazzi
    Policlinico San Matteo, IRCCS, Pavia, Italy
    Eur J Heart Fail 6:635-41. 2004
    ..The GISSI Heart Failure project is a large-scale, randomized, double-blind study designed to investigate the effects of n-3 polyunsaturated fatty acids and rosuvastatin on mortality and morbidity in patients with symptomatic heart failure...
  38. ncbi request reprint Current presentation and management of heart failure in cardiology and internal medicine hospital units: a tale of two worlds--the TEMISTOCLE study
    Andrea Di Lenarda
    Maggiore Hospital, Department of Cardiology, Trieste, Italy
    Am Heart J 146:E12. 2003
    ..The purpose pf the current article is to describe the clinical profile, use of resources, management and outcome in a population of real-world inpatients with heart failure...
  39. ncbi request reprint Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry)
    Giovanni Pulignano
    Department of Cardiology, S Camillo Hospital, Institute of Care and Research, Rome, Italy
    Am Heart J 143:45-55. 2002
    ..Despite the high mortality and morbidity in elderly patients with HF, limited clinical and prognostic data are available for development of appropriate prevention and treatment strategies...
  40. ncbi request reprint Survival and hospitalization in heart failure patients with or without diabetes treated with beta-blockers
    Marco Bobbio
    University Division of Cardiology, Turin, Italy
    J Card Fail 9:192-202. 2003
    ..Physicians are still concerned about prescribing beta-blockers in diabetic patients with heart failure...
  41. ncbi request reprint Ergometric score systems after myocardial infarction: prognostic performance of the Duke Treadmill Score, Veterans Administration Medical Center Score, and of a novel score system, GISSI-2 Index, in a cohort of survivors of acute myocardial infarction
    Massimo Villella
    Cardiology Department, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Italy
    Am Heart J 145:475-83. 2003
    ....
  42. ncbi request reprint Clinical features and prognosis associated with a preserved left ventricular systolic function in a large cohort of congestive heart failure outpatients managed by cardiologists. Data from the Italian Network on Congestive Heart Failure
    Luigi Tarantini
    Department of Cardiology, San Martino Hospital, Belluno, Italy
    Ital Heart J 3:656-64. 2002
    ....
  43. ncbi request reprint Prognosis of inappropriate left ventricular mass in hypertension: the MAVI Study
    Giovanni de Simone
    Department of Clinical and Experimental Medicine, School of Medicine, Federico II University Hospital, Naples, Italy
    Hypertension 40:470-6. 2002
    ..01). Thus, inappropriate LV mass predicts a risk of cardiovascular events, independently of risk factors, and remains a significant predictor of risk either in the presence or in the absence of traditionally defined LV hypertrophy...
  44. ncbi request reprint Clinical value of 12-lead electrocardiography to predict the long-term prognosis of GISSI-1 patients
    Francesco Mauri
    Division of Cardiology, Ospedale Niguarda Ca Granda, Milano, Italy
    J Am Coll Cardiol 39:1594-600. 2002
    ....
  45. ncbi request reprint [The AREA IN-CHF trial (antiremodeling effect of aldosterone receptors blockade with canrenone in mild chronic heart failure): rationale and design]
    Giuseppe Cacciatore
    U O C di Cardiologia, Azienda Ospedaliera San Giovanni Addolorata, Roma
    Ital Heart J 6:66S-74S. 2005
    ..Therefore it seems interesting to evaluate the effect of canrenone, an aldosterone receptor blocker, on the progression of left ventricular dysfunction in patients with mild heart failure assuming standard therapy...
  46. ncbi request reprint Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids
    Alejandro Macchia
    Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti, Italy
    Eur J Heart Fail 7:904-9. 2005
    ..In GISSI-Prevenzione, treatment with n-3 polyunsaturated fatty acids (PUFA) reduced M and SD in post-MI patients, but their effect in patients with SyD is unknown...
  47. ncbi request reprint Left bundle branch block as a risk factor for progression to heart failure
    Faiez Zannad
    CIC INSERM CHU de Nancy, Hopital Jeanne d Arc, Dommartin les Toul, BP 303 54201 Toul Cedex, France
    Eur J Heart Fail 9:7-14. 2007
    ..It also aims to address the potential for future clinical therapies for this conduction disorder...
  48. ncbi request reprint [Heart rate as a therapeutic target for stable angina. Role of anti-ischemic agents and their underuse in Italy]
    Gianni Casella
    U O di Cardiologia, Ospedale Maggiore, Bologna
    G Ital Cardiol (Rome) 8:207-14. 2007
    ....
  49. ncbi request reprint GlObal Secondary Prevention strategiEs to Limit event recurrence after myocardial infarction: the GOSPEL study. A trial from the Italian Cardiac Rehabilitation Network: rationale and design
    Pantaleo Giannuzzi
    Salvatore Maugeri Foundation, IRCCS, Veruno, Italy
    Eur J Cardiovasc Prev Rehabil 12:555-61. 2005
    ....
  50. ncbi request reprint Efficacy of n-3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the GISSI-Prevenzione trial
    Roberto Marchioli
    Consorzio Mario Negri Sud, Santa Maria Imbaro CH, Italy
    J Cardiovasc Med (Hagerstown) 8:S34-7. 2007
    ..We found no evidence that concomitant disease states, habits, or interventions altered the therapeutic benefit of n-3 PUFA consumption in survivors of recent myocardial infarction...
  51. ncbi request reprint Coffee consumption and risk of cardiovascular events after acute myocardial infarction: results from the GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico)-Prevenzione trial
    Maria Giuseppina Silletta
    Laboratory of Clinical Epidemiology of Cardiovascular Disease, Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti, Italy
    Circulation 116:2944-51. 2007
    ..The relation between coffee consumption and cardiovascular disease has been studied extensively, but results are still debated. In addition, little evidence is available on patients with established coronary heart disease...
  52. ncbi request reprint [Obesity paradox in patients with coronary artery disease or heart failure]
    Stefano De Servi
    Dipartimento Cardiovascolare, AO Ospedale Civile, Legnano
    G Ital Cardiol (Rome) 9:60S-66S. 2008
    ..In these clinical conditions, prospective studies to assess the role of intentional weight loss should be specifically designed...
  53. ncbi request reprint [Observational research: a fundamental tool for clinical practice]
    Luigi Tavazzi
    Dipartimento di Cardiologia, IRCCS Policlinico San Matteo, Pavia
    Ital Heart J Suppl 6:682-9. 2005
  54. doi request reprint Omega-3 fatty acid supplementation reduces one-year risk of atrial fibrillation in patients hospitalized with myocardial infarction
    Alejandro Macchia
    Department of Clinical Pharmacology and Epidemiology, Santa Maria Imbaro, Chieti, Italy
    Eur J Clin Pharmacol 64:627-34. 2008
    ..Current strategies for avoiding atrial fibrillation (AF) are of limited value. We aim to assess the relationship between omega-3 fatty acids (n-3 PUFA) and AF occurrence in post-myocardial infarction (MI) patients...
  55. ncbi request reprint [Ongoing trials and future prospects]
    Samuele Baldasseroni
    Centro Studi ANMCO, Via La Marmora, 34 50121 Firenze
    Ital Heart J 4:58S-64S. 2003
    ....
  56. ncbi request reprint [Diabetes mellitus, left ventricular dysfunction and congestive heart failure]
    Luigi Tarantini
    Divisione di Cardiologia, Ospedale San Martino, Belluno
    Ital Heart J Suppl 5:605-15. 2004
    ....
  57. ncbi request reprint Clinical characteristics and outcome of diabetic patients with acute myocardial infarction. Data from the BLITZ-1 study
    Gianni Casella
    Ospedale Maggiore, Bologna, Italy
    Ital Heart J 6:374-83. 2005
    ....
  58. ncbi request reprint Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione
    Roberto Marchioli
    Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti, Italy
    Circulation 105:1897-903. 2002
    ..Our purpose was to assess the time course of the benefit of n-3 polyunsaturated fatty acids (PUFAs) on mortality documented by the GISSI-Prevenzione trial in patients surviving a recent (<3 months) myocardial infarction...